PYLARIFY ® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with ...

For more information about PYLCLARI ®: www.pylclari.com In the U.S., Lantheus received approval for PYLARIFY ® (Piflufolastat ... It is the #1 utilized PSMA PET agent in the U.S. market.